Research:

• Pharmacogenomics of low dose empagliflozin and its association with treatment outcomes with heart failure.
• The association of DHODH ,CYPIA2,and ABCG2 gene polymorphism on efficacy and toxicity of leflunomide in the management of rheumatoid arthritis.
• Association of CYP3A5,ABCC2and POR genetic polymorphisms on tacrolimus efficacy and adverse effects in liver transplant recipients.